TGTGInsighttelegram intelligenceLIVE / telegram public index
← OnePlus Guide

TGINSIGHT SIMILAR POSTS

Trouver du contenu similaire

Chaîne source @OnePlusGuide · Post #2744 · 23 août

🔻SERIE ONEPLUS NORD: 2 NUOVI MODELLI IN ARRIVO?🔻 #ONEPLUS Vi ricordate dei rumor su Billie, il potenziale fratellino low-cost del OnePlus Nord? (Se non sapete di cosa sto parlando, tappatequi) Negli ultimi giorni girano voci (appoggiate dal noto leaker Max J) che sui siti di benchmark siano apparsi Billie 1 e Billie 2, quindi non uno ma ben due smartphone low-cost firmati OnePlus. Riassunto in poche righe, ecco quello di cui si è parlato finora: Vendita ristretta solo agli USA, retro in plastica, Snapdragon 690 5G, carica che arriva solo alla 18W. Vi potrebbero interessare? Fatecelo sapere nei nostri gruppi! Pit — Il nostro canale 👉🏻@oneplusguide I nostri gruppi 👉🏻@oneplusitcommunity

Hashtags

Résultats

1 post similaire trouvé

Recherche : #signalprocessing

当前筛选 #signalprocessing清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3912 · 18/01/2025 10:00

$51M Raised Across Multiple Startups Ten innovative startups secured funding in January 2025, totaling $51 million. Highlights include: - Merit Systems: $10M for an open-source economy. - Botika: $8M, leading in AI-generated fashion models. - Underdogs: $6.13M, focused on training entrepreneurs. - TrustUp: $5.18M in health tech innovation. - Elcogen: $5M in efficient fuel cell manufacturing. - Convergence Medical Robotics: $5M for medical robotics solutions. - Constelli: $3M in signal processing for defense. - Immunocure Discovery Solutions: $3M in AI drug discovery services. - Naco: $2.58M for nano coatings in fuel cells. - TalentMapper: $2.44M for talent management solutions. Read more: Merit Systems | Botika | Underdogs | TrustUp | Elcogen | Convergence Medical Robotics | Constelli | Immunocure Discovery Solutions | Naco | TalentMapper #StartupFunding#OpenSource#AI#FashionTech#Education#HealthTech#FuelCells#Innovation#SignalProcessing#DrugDiscovery#NanoTech#HydrogenEnergy#MedTech#VC